Shenzhen Hepalink Pharmaceutical Group (SHEZF) Stock Price, News & Analysis

Company Overview

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a China-based pharmaceutical company specializing in the production and development of heparin and related anticoagulant products. As one of the largest manufacturers of animal-derived heparin, the company offers a portfolio that includes unfractionated heparin, low molecular weight heparins and mucopolysaccharide-derived APIs. Its integrated operations span from raw material sourcing and active pharmaceutical ingredient (API) manufacturing to finished dosage formulation.

Beyond its core anticoagulant business, Hepalink has extended its capabilities into advanced biologic research and development. The company supports ongoing programs in novel antithrombotic agents and has begun preliminary work in cell and gene therapy platforms. Through strategic investments in pilot production facilities and collaborations with academic partners, it aims to broaden its product pipeline and address emerging healthcare needs.

Headquartered in Shenzhen, Guangdong province, Hepalink serves hospitals, distributors and pharmaceutical partners across mainland China and maintains an export network reaching Europe, North America and other markets in Asia. Since its establishment, the group has pursued capacity expansions and logistical enhancements to support global supply chains and respond to evolving regulatory requirements in key markets.

Key Stats

• Today's Range: $0.47 to $0.47
• 50-Day Range: $0.47 to $0.47
• 52-Week Range: $0.47 to $0.47
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: 6.79
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SHEZF Stock Analysis - Frequently Asked Questions

How have SHEZF shares performed this year?

Shenzhen Hepalink Pharmaceutical Group's stock was trading at $0.4696 at the beginning of 2025. Since then, SHEZF shares have increased by 0.0% and is now trading at $0.4696.

How do I buy shares of Shenzhen Hepalink Pharmaceutical Group?

Shares of SHEZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SHEZF
• CIK: N/A
• Web: www.hepalink.com
• Phone: 86-755-2698-0200
• Fax: N/A
• Employees: 2,080
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 6.79
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A